Literature DB >> 24993300

Tumor necrosis factor-α-stimulated brain pericytes possess a unique cytokine and chemokine release profile and enhance microglial activation.

Junichi Matsumoto1, Fuyuko Takata2, Takashi Machida3, Hiroyuki Takahashi4, Yuki Soejima5, Miho Funakoshi6, Koujiro Futagami7, Atsushi Yamauchi8, Shinya Dohgu9, Yasufumi Kataoka10.   

Abstract

Brain pericytes are involved in neurovascular dysfunction, neurodegeneration and/or neuroinflammation. In the present study, we focused on the proinflammatory properties of brain pericytes to understand their participation in the induction of inflammation at the neurovascular unit (NVU). The NVU comprises different cell types, namely, brain microvascular endothelial cells, pericytes, astrocytes and microglia. Among these, we found pericytes to be the most sensitive to tumor necrosis factor (TNF)-α, possessing a unique cytokine and chemokine release profile. This was characterized by marked release of interleukin (IL)-6 and macrophage inflammatory protein-1α. Furthermore, TNF-α-stimulated pericytes induced expression of inducible nitric oxide synthase and IL-1β mRNAs, as an index of BV-2 microglial cell activation state, to the highest levels. Based on these findings, the possibility that brain pericytes act specifically as TNF-α-sensitive cells and as effectors of TNF-α through the release of proinflammatory factors, and that, as such, they have a role in inducing brain inflammation, should be considered.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Brain inflammation; Microglia; Neurovascular unit; Pericytes; Tumor necrosis factor-α

Mesh:

Substances:

Year:  2014        PMID: 24993300     DOI: 10.1016/j.neulet.2014.06.052

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  31 in total

Review 1.  Microglial interactions with the neurovascular system in physiology and pathology.

Authors:  Xiaoliang Zhao; Ukpong B Eyo; Madhuvika Murugan; Long-Jun Wu
Journal:  Dev Neurobiol       Date:  2018-02-01       Impact factor: 3.964

Review 2.  Improving CNS Delivery to Brain Metastases by Blood-Tumor Barrier Disruption.

Authors:  Samuel A Sprowls; Tasneem A Arsiwala; Jacob R Bumgarner; Neal Shah; Sundus S Lateef; Brooke N Kielkowski; Paul R Lockman
Journal:  Trends Cancer       Date:  2019-07-20

Review 3.  The Blood-Brain Barrier: Much More Than a Selective Access to the Brain.

Authors:  Fredy Sanchez-Cano; Luisa C Hernández-Kelly; Arturo Ortega
Journal:  Neurotox Res       Date:  2021-10-22       Impact factor: 3.911

Review 4.  A role for pericytes in chronic pain?

Authors:  Alexandra M Durrant; Matthew N Swift; Nicholas Beazley-Long
Journal:  Curr Opin Support Palliat Care       Date:  2018-06       Impact factor: 2.302

5.  Pathology of the neurovascular unit in leukodystrophies.

Authors:  Parand Zarekiani; Marjolein Breur; Nicole I Wolf; Helga E de Vries; Marjo S van der Knaap; Marianna Bugiani
Journal:  Acta Neuropathol Commun       Date:  2021-06-03       Impact factor: 7.801

Review 6.  Links between Immune Cells from the Periphery and the Brain in the Pathogenesis of Epilepsy: A Narrative Review.

Authors:  Gaku Yamanaka; Shinichiro Morichi; Tomoko Takamatsu; Yusuke Watanabe; Shinji Suzuki; Yu Ishida; Shingo Oana; Takashi Yamazaki; Fuyuko Takata; Hisashi Kawashima
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

7.  TGF-beta1 regulates human brain pericyte inflammatory processes involved in neurovasculature function.

Authors:  Justin Rustenhoven; Miranda Aalderink; Emma L Scotter; Robyn L Oldfield; Peter S Bergin; Edward W Mee; E Scott Graham; Richard L M Faull; Maurice A Curtis; Thomas I-H Park; Mike Dragunow
Journal:  J Neuroinflammation       Date:  2016-02-11       Impact factor: 8.322

8.  Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology.

Authors:  Karen Horsburgh; Joanna M Wardlaw; Tom van Agtmael; Stuart M Allan; Mike L J Ashford; Philip M Bath; Rosalind Brown; Jason Berwick; M Zameel Cader; Roxana O Carare; John B Davis; Jessica Duncombe; Tracy D Farr; Jill H Fowler; Jozien Goense; Alessandra Granata; Catherine N Hall; Atticus H Hainsworth; Adam Harvey; Cheryl A Hawkes; Anne Joutel; Rajesh N Kalaria; Patrick G Kehoe; Catherine B Lawrence; Andy Lockhart; Seth Love; Malcolm R Macleod; I Mhairi Macrae; Hugh S Markus; Chris McCabe; Barry W McColl; Paul J Meakin; Alyson Miller; Maiken Nedergaard; Michael O'Sullivan; Terry J Quinn; Rikesh Rajani; Lisa M Saksida; Colin Smith; Kenneth J Smith; Rhian M Touyz; Rebecca C Trueman; Tao Wang; Anna Williams; Steven C R Williams; Lorraine M Work
Journal:  Clin Sci (Lond)       Date:  2018-04-30       Impact factor: 6.124

9.  VEGFA165 gene therapy ameliorates blood-labyrinth barrier breakdown and hearing loss.

Authors:  Jinhui Zhang; Zhiqiang Hou; Xiaohan Wang; Han Jiang; Lingling Neng; Yunpei Zhang; Qing Yu; George Burwood; Junha Song; Manfred Auer; Anders Fridberger; Michael Hoa; Xiaorui Shi
Journal:  JCI Insight       Date:  2021-04-22

10.  Cerebral Pericytes and Endothelial Cells Communicate through Inflammasome-Dependent Signals.

Authors:  Mihály Kozma; Ádám Mészáros; Ádám Nyúl-Tóth; Kinga Molnár; Laura Costea; Zsófia Hernádi; Csilla Fazakas; Attila E Farkas; Imola Wilhelm; István A Krizbai
Journal:  Int J Mol Sci       Date:  2021-06-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.